2022-10-012023-09-302023-09-30false13644373FUNCTIONAL NUTRITION CLINIC LIMITED2023-10-1886900iso4217:GBPxbrli:pure136443732022-10-01136443732023-09-30136443732022-10-012023-09-30136443732021-09-27136443732022-09-30136443732021-09-272022-09-3013644373bus:SmallEntities2022-10-012023-09-3013644373bus:AuditExempt-NoAccountantsReport2022-10-012023-09-3013644373bus:AbridgedAccounts2022-10-012023-09-3013644373bus:PrivateLimitedCompanyLtd2022-10-012023-09-3013644373core:WithinOneYear2023-09-3013644373core:AfterOneYear2023-09-3013644373core:WithinOneYear2022-09-3013644373core:AfterOneYear2022-09-3013644373core:ShareCapital2023-09-3013644373core:SharePremium2023-09-3013644373core:RevaluationReserve2023-09-3013644373core:OtherReservesSubtotal2023-09-3013644373core:RetainedEarningsAccumulatedLosses2023-09-3013644373core:ShareCapital2022-09-3013644373core:SharePremium2022-09-3013644373core:RevaluationReserve2022-09-3013644373core:OtherReservesSubtotal2022-09-3013644373core:RetainedEarningsAccumulatedLosses2022-09-3013644373core:LandBuildings2023-09-3013644373core:PlantMachinery2023-09-3013644373core:Vehicles2023-09-3013644373core:FurnitureFittings2023-09-3013644373core:OfficeEquipment2023-09-3013644373core:NetGoodwill2023-09-3013644373core:IntangibleAssetsOtherThanGoodwill2023-09-3013644373core:ListedExchangeTraded2023-09-3013644373core:UnlistedNon-exchangeTraded2023-09-3013644373core:LandBuildings2022-09-3013644373core:PlantMachinery2022-09-3013644373core:Vehicles2022-09-3013644373core:FurnitureFittings2022-09-3013644373core:OfficeEquipment2022-09-3013644373core:NetGoodwill2022-09-3013644373core:IntangibleAssetsOtherThanGoodwill2022-09-3013644373core:ListedExchangeTraded2022-09-3013644373core:UnlistedNon-exchangeTraded2022-09-3013644373core:LandBuildings2022-10-012023-09-3013644373core:PlantMachinery2022-10-012023-09-3013644373core:Vehicles2022-10-012023-09-3013644373core:FurnitureFittings2022-10-012023-09-3013644373core:OfficeEquipment2022-10-012023-09-3013644373core:NetGoodwill2022-10-012023-09-3013644373core:IntangibleAssetsOtherThanGoodwill2022-10-012023-09-3013644373core:ListedExchangeTraded2022-10-012023-09-3013644373core:UnlistedNon-exchangeTraded2022-10-012023-09-3013644373core:MoreThanFiveYears2022-10-012023-09-3013644373core:Non-currentFinancialInstruments2023-09-3013644373core:Non-currentFinancialInstruments2022-09-3013644373dpl:CostSales2022-10-012023-09-3013644373dpl:DistributionCosts2022-10-012023-09-3013644373core:LandBuildings2022-10-012023-09-3013644373core:PlantMachinery2022-10-012023-09-3013644373core:Vehicles2022-10-012023-09-3013644373core:FurnitureFittings2022-10-012023-09-3013644373core:OfficeEquipment2022-10-012023-09-3013644373dpl:AdministrativeExpenses2022-10-012023-09-3013644373core:NetGoodwill2022-10-012023-09-3013644373core:IntangibleAssetsOtherThanGoodwill2022-10-012023-09-3013644373dpl:GroupUndertakings2022-10-012023-09-3013644373dpl:ParticipatingInterests2022-10-012023-09-3013644373dpl:GroupUndertakingscore:ListedExchangeTraded2022-10-012023-09-3013644373core:ListedExchangeTraded2022-10-012023-09-3013644373dpl:GroupUndertakingscore:UnlistedNon-exchangeTraded2022-10-012023-09-3013644373core:UnlistedNon-exchangeTraded2022-10-012023-09-3013644373dpl:CostSales2021-09-272022-09-3013644373dpl:DistributionCosts2021-09-272022-09-3013644373core:LandBuildings2021-09-272022-09-3013644373core:PlantMachinery2021-09-272022-09-3013644373core:Vehicles2021-09-272022-09-3013644373core:FurnitureFittings2021-09-272022-09-3013644373core:OfficeEquipment2021-09-272022-09-3013644373dpl:AdministrativeExpenses2021-09-272022-09-3013644373core:NetGoodwill2021-09-272022-09-3013644373core:IntangibleAssetsOtherThanGoodwill2021-09-272022-09-3013644373dpl:GroupUndertakings2021-09-272022-09-3013644373dpl:ParticipatingInterests2021-09-272022-09-3013644373dpl:GroupUndertakingscore:ListedExchangeTraded2021-09-272022-09-3013644373core:ListedExchangeTraded2021-09-272022-09-3013644373dpl:GroupUndertakingscore:UnlistedNon-exchangeTraded2021-09-272022-09-3013644373core:UnlistedNon-exchangeTraded2021-09-272022-09-3013644373core:NetGoodwill2023-09-3013644373core:IntangibleAssetsOtherThanGoodwill2023-09-3013644373core:LandBuildings2023-09-3013644373core:PlantMachinery2023-09-3013644373core:Vehicles2023-09-3013644373core:FurnitureFittings2023-09-3013644373core:OfficeEquipment2023-09-3013644373core:AfterOneYear2023-09-3013644373core:WithinOneYear2023-09-3013644373core:ListedExchangeTraded2023-09-3013644373core:UnlistedNon-exchangeTraded2023-09-3013644373core:ShareCapital2023-09-3013644373core:SharePremium2023-09-3013644373core:RevaluationReserve2023-09-3013644373core:OtherReservesSubtotal2023-09-3013644373core:RetainedEarningsAccumulatedLosses2023-09-3013644373core:NetGoodwill2022-09-3013644373core:IntangibleAssetsOtherThanGoodwill2022-09-3013644373core:LandBuildings2022-09-3013644373core:PlantMachinery2022-09-3013644373core:Vehicles2022-09-3013644373core:FurnitureFittings2022-09-3013644373core:OfficeEquipment2022-09-3013644373core:AfterOneYear2022-09-3013644373core:WithinOneYear2022-09-3013644373core:ListedExchangeTraded2022-09-3013644373core:UnlistedNon-exchangeTraded2022-09-3013644373core:ShareCapital2022-09-3013644373core:SharePremium2022-09-3013644373core:RevaluationReserve2022-09-3013644373core:OtherReservesSubtotal2022-09-3013644373core:RetainedEarningsAccumulatedLosses2022-09-3013644373core:NetGoodwill2021-09-2713644373core:IntangibleAssetsOtherThanGoodwill2021-09-2713644373core:LandBuildings2021-09-2713644373core:PlantMachinery2021-09-2713644373core:Vehicles2021-09-2713644373core:FurnitureFittings2021-09-2713644373core:OfficeEquipment2021-09-2713644373core:AfterOneYear2021-09-2713644373core:WithinOneYear2021-09-2713644373core:ListedExchangeTraded2021-09-2713644373core:UnlistedNon-exchangeTraded2021-09-2713644373core:ShareCapital2021-09-2713644373core:SharePremium2021-09-2713644373core:RevaluationReserve2021-09-2713644373core:OtherReservesSubtotal2021-09-2713644373core:RetainedEarningsAccumulatedLosses2021-09-2713644373core:AfterOneYear2022-10-012023-09-3013644373core:WithinOneYear2022-10-012023-09-3013644373core:Non-currentFinancialInstrumentscore:CostValuation2022-10-012023-09-3013644373core:Non-currentFinancialInstrumentscore:AdditionsToInvestments2022-10-012023-09-3013644373core:Non-currentFinancialInstrumentscore:RevaluationsIncreaseDecreaseInInvestments2022-10-012023-09-3013644373core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInInvestments2022-10-012023-09-3013644373core:Non-currentFinancialInstrumentscore:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments2022-10-012023-09-3013644373core:Non-currentFinancialInstrumentscore:ImpairmentLossReversalProvisionsForImpairmentInvestments2022-10-012023-09-3013644373core:Non-currentFinancialInstrumentscore:AcquisitionsIncreaseInProvisionsForImpairmentInvestments2022-10-012023-09-3013644373core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInProvisionsForImpairmentInvestments2022-10-012023-09-3013644373core:Non-currentFinancialInstrumentscore:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments2022-10-012023-09-3013644373core:Non-currentFinancialInstrumentscore:CostValuation2023-09-3013644373core:Non-currentFinancialInstrumentscore:AdditionsToInvestments2023-09-3013644373core:Non-currentFinancialInstrumentscore:RevaluationsIncreaseDecreaseInInvestments2023-09-3013644373core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInInvestments2023-09-3013644373core:Non-currentFinancialInstrumentscore:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments2023-09-3013644373core:Non-currentFinancialInstrumentscore:ImpairmentLossReversalProvisionsForImpairmentInvestments2023-09-3013644373core:Non-currentFinancialInstrumentscore:AcquisitionsIncreaseInProvisionsForImpairmentInvestments2023-09-3013644373core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInProvisionsForImpairmentInvestments2023-09-3013644373core:Non-currentFinancialInstrumentscore:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments2023-09-3013644373core:Non-currentFinancialInstrumentscore:CostValuation2022-09-3013644373core:Non-currentFinancialInstrumentscore:AdditionsToInvestments2022-09-3013644373core:Non-currentFinancialInstrumentscore:RevaluationsIncreaseDecreaseInInvestments2022-09-3013644373core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInInvestments2022-09-3013644373core:Non-currentFinancialInstrumentscore:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments2022-09-3013644373core:Non-currentFinancialInstrumentscore:ImpairmentLossReversalProvisionsForImpairmentInvestments2022-09-3013644373core:Non-currentFinancialInstrumentscore:AcquisitionsIncreaseInProvisionsForImpairmentInvestments2022-09-3013644373core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInProvisionsForImpairmentInvestments2022-09-3013644373core:Non-currentFinancialInstrumentscore:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments2022-09-3013644373bus:Director12022-10-012023-09-3013644373bus:Director22022-10-012023-09-30

FUNCTIONAL NUTRITION CLINIC LIMITED

Registered Number
13644373
(England and Wales)

Unaudited Financial Statements for the Year ended
30 September 2023

FUNCTIONAL NUTRITION CLINIC LIMITED
Company Information
for the year from 1 October 2022 to 30 September 2023

Directors

CHESWORTH, Emma Alexandra Louise
CROXFORD, Emma Margareta

Registered Address

1 Washington Road
London
SW13 9BG

Registered Number

13644373 (England and Wales)
FUNCTIONAL NUTRITION CLINIC LIMITED
Balance Sheet as at
30 September 2023

Notes

2023

2022

£

£

£

£

Current assets
Cash at bank and on hand5802,021
5802,021
Creditors amounts falling due within one year5(8,709)(5,081)
Net current assets (liabilities)(8,129)(3,060)
Total assets less current liabilities(8,129)(3,060)
Net assets(8,129)(3,060)
Capital and reserves
Profit and loss account(8,129)(3,060)
Shareholders' funds(8,129)(3,060)
The financial statements were approved and authorised for issue by the Board of Directors on 18 October 2023, and are signed on its behalf by:
CROXFORD, Emma Margareta
Director
Registered Company No. 13644373
FUNCTIONAL NUTRITION CLINIC LIMITED
Notes to the Financial Statements
for the year ended 30 September 2023

1.Statutory information
The company is a private company limited by shares and registered in England and Wales. The company's registered number and registered office address can be found on the Company Information page.
2.Compliance with applicable reporting framework
The financial statements have been prepared in compliance with FRS 102 Section 1A as it applies to the financial statements for the period and there were no material departures from the reporting standard.
3.Accounting policies
Revenue recognition policy
Turnover from the sale of goods is recognised when the significant risks and rewards of ownership of the goods have transferred to the buyer. Turnover from the rendering of services is recognised by reference to the stage of completion of the contract. The stage of completion of a contract is measured by comparing the costs incurred for work performed to date to the total estimated contract costs.
Foreign currency translation and operations policy
Transactions in foreign currencies are initially recognised at the rate of exchange ruling at the date of the transaction. At the end of each reporting period foreign currency monetary items are translated at the closing rate of exchange. Non-monetary items that are measured at historical cost are translated at the rate ruling at the date of the transaction. All differences are charged to profit or loss.
4.Employee information

20232022
Average number of employees during the year22
5.Creditors within one year

2023

2022

££
Trade creditors / trade payables-589
Other creditors8,7094,492
Total8,7095,081
Short term creditors are measured at transaction price (which is usually the invoice price). Loans and other financial liabilities are initially recognised at transaction price net of any transaction costs and subsequently measured at amortised cost determined using the effective interest method.